Nurse Practitioner, Acute Care · New York, NY
NPI
1699497719
Since 2022
Specialty
Nurse Practitioner, Acute Care
Code 363LA2100X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1283 York Ave 9th Floor
New York, NY, 10065
Phone (646) 962-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$23K
329 services
Medicare patients, 2024
271
Average age 73
Drug cost, 2024
$711K
1,163 prescriptions
Company payments, 2025
$338
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tiffany K Min was code 99214 (office e&m - established), 104 times for 81 patients. In total Tiffany K Min billed 329 services in 6 codes, and Medicare paid $23K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 104 | 81 | $67.72 | $7,043 |
| 99214 Office E&M - Established | Office | 75 | 65 | $89.11 | $6,683 |
| 99203 Office E&M - New | Office | 66 | 66 | $68.62 | $4,529 |
| 99203 Office E&M - New | Facility | 54 | 54 | $49.92 | $2,696 |
| 99213 Office E&M - Established | Facility | 11 | 11 | $48.86 | $537 |
By year: 2023 $4,170 for 64 services; 2024 $23K for 329 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tiffany K Min prescribed most often to Medicare patients was Omeprazole, with 167 prescriptions and refills. In total Tiffany K Min wrote 1,163 Medicare prescriptions that cost $711K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 167 | 420 | 72 | $2,537 |
| Pantoprazole Sodium Generic | 93 | 209 | 29 | $2,536 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 63 | 63 | 62 | $786 |
| Linzess Linaclotide | 54 | 70 | 15 | $37K |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 54 | 65 | 51 | $780 |
| Famotidine Generic | 54 | 148 | 29 | $846 |
| Voquezna Vonoprazan Fumarate | 48 | 54 | 21 | $34K |
| Motegrity Prucalopride Succinate | 40 | 68 | 13 | $35K |
| Vancomycin Hcl Generic | 29 | 33 | 17 | $2,201 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 25 | 25 | Under 11 | $783 |
| Dicyclomine Hcl Generic | 23 | 29 | 11 | $456 |
| Metoclopramide Hcl Generic | 23 | 47 | Under 11 | $239 |
| Dificid Fidaxomicin | 20 | 20 | Under 11 | $96K |
| Dexlansoprazole Dr Dexlansoprazole | 19 | 23 | Under 11 | $7,515 |
| Apriso Mesalamine | 19 | 19 | Under 11 | $9,005 |
Brand drugs: 324 claims; generic drugs: 821 claims; opioid claims: 37.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tiffany K Min $338 ($338 in general payments such as food, travel and fees) from 3 companies. The largest payer was Aimmune Therapeutics, Inc. with $194.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.